Epidemiology’s coverage of dry eye disease (DED) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of DED for each country, as well as annualized case counts projected to the national population. Patient populations are forecast over a period of 20 years.
DRG Epidemiology’s DED forecast will answer the following questions:
Of all people with DED, how many in each of the major mature pharmaceutical markets have been formally diagnosed?
Of all people diagnosed with DED, how many in each of the major mature pharmaceutical markets have mild, moderate, or severe disease?
How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of DED over the forecast period?
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In addition to the total number of cases for each forecast year, DRG Epidemiology provides at least ten years of forecast data for the following DED subpopulations:
Diagnosed Prevalence of Dry Eye per 100 People Aged 20+ in 2021 and 2041
Relative Sizes of the Factors Contributing to the Trend in Diagnosed Prevalent Cases of Dry Eye Over the Next 20 Yearsttttttttt
Analysis of Diagnosed Prevalent Cases of Dry Eye in the Countries Under Study in 2021 by Severity
Epidemiology Data
Methods
Total Prevalent Cases
Diagnosed Prevalent Cases of Dry Eye
Diagnosed Prevalent Cases of Dry Eye by Severity
Drug-Treated Prevalent Cases of Dry Eye
Reference Materials
Literature Review
Studies Included in the Analysis of Dry Eye Disease
Studies Excluded from the Analysis of Dry Eye Disease
Risk / Protective Factors
Risk / Protective Factors for Dry Eye Disease
Bibliography
Abbreviations
Glossary
Prashant Kumar
Swarali Tadwalkar, M.P.H., is a principal epidemiologist at Clarivate. Previously, she was involved in primary and secondary healthcare research, including projects in digital health, health policy and management, and health economics and outcomes research (HEOR). Ms. Tadwalkar also coordinated various nongovernmental public health projects focusing on access to treatment for hepatitis and human papilloma virus. She received her M.P.H. from the University of South Florida in Tampa.
